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Atrial fibrillation (AF) increases the risk of stroke by a factor of four to five and is the most com-
mon abnormal heart rhythm. The progression of AF with age, from short self-terminating episodes
to persistence, varies between individuals and is poorly understood. An inability to understand and
predict variation in AF progression has resulted in less patient-specific therapy. Likewise, it has been
a challenge to relate the microstructural features of heart muscle tissue (myocardial architecture)
with the emergent temporal clinical patterns of AF. We use a simple model of activation wavefront
propagation on an anisotropic structure, mimicking heart muscle tissue, to show how variation in
AF behaviour arises naturally from microstructural differences between individuals. We show that
the stochastic nature of progressive transversal uncoupling of muscle strands (e.g., due to fibrosis
or gap junctional remodelling), as occurs with age, results in variability in AF episode onset time,
frequency, duration, burden and progression between individuals. This is consistent with clinical
observations. The uncoupling of muscle strands can cause critical architectural patterns in the my-
ocardium. These critical patterns anchor micro-re-entrant wavefronts and thereby trigger AF. It
is the number of local critical patterns of uncoupling as opposed to global uncoupling that deter-
mines AF progression. This insight may eventually lead to patient specific therapy when it becomes
possible to observe the cellular structure of a patient’s heart.
A key challenge in the mathematical modelling of dis-
eases is to link microscopic variation in individuals (e.g.,
genetic, metabolic or tissue structure) to variation in dis-
ease outcomes (e.g., the occurrence, recurrence or persis-
tence of AF). In this paper we show how variation in
microstructure affects the behaviour of AF, suggesting
a single mechanism for the origin of clinically observed
variability of AF behaviour. Atrial fibrillation is charac-
terised by the apparently random propagation of multi-
ple activation wavefronts in atrial muscle (myocardium).
This gives rise to AF episodes of variable duration. Typi-
cally, short self-terminating episodes become longer with
time until they do not terminate spontaneously. Cur-
rent clinical guidelines (ACA/AGA/ESC) define AF by
the episode duration as paroxysmal (< 7 days), persis-
tent (> 7 days), long-standing persistent (> 1 year) and
permanent (clinical decision to not treat) [1]. However,
AF episodes will in fact lie on a continuum of durations.
The natural history of AF is usually discussed using this
classification scheme which by its technical definition al-
lows for progression of paroxysmal to persistent but not
the reverse. However, this classification scheme becomes
problematic in cases where episodes lasting longer than 7
days terminate and are followed by episodes shorter than
7 days which is observed to occur frequently in patients
[2]. Indeed, Sugihara et al [3]. could not consistently
apply these guidelines to their continuously monitored
patients because AF episode durations were observed to
remit from more than 7 days to less than 7 days. Hence,
they defined a different classification scheme based on AF
burden (fraction of time in AF) to describe their obser-
vations rather an arbitrary 7 day cut-off to distinguish
between patients. It has been suggested that AF induces
atrial electrophysiological changes (e.g., action potential
duration shortening) and microstructural changes (e.g.,
fibrosis or gap junctional uncoupling), which promote
further AF. This self-perpetuation has been termed AF
begets AF [4]. Whilst fibrosis promotes AF, the quanti-
tative relationship and the mechanism by which fibrosis
promotes AF is not fully understood [5].
Sugihara et al. [3] monitored AF patients continu-
ously in a long term study (1031 cumulative patient-
years, mean 3.2 years per patient) using dual chamber
permanent pacemakers. It was observed that progression
to persistent AF was not inevitable, that is, some pa-
tients remained paroxysmal for the duration of the long
term follow-up and some patients’ AF burden (fraction
of time in AF) could remit from 100 % to less than 100 %
and relapse to 100% again. Indeed it has been observed
that some patients do not progress from paroxysmal to
persistent AF, using current clinical guidelines, after as
many as 22 years [6]. Veasey et al. [2] also used con-
tinuous monitoring data to show that after a mean 7
year follow up, 35 % of patients that were initially clas-
sified as persistent AF using the current clinical guide-
lines were re-classified as paroxysmal AF. Other research
has shown that the time course of AF is seen to vary
between patients with similar fibrosis burden: some pa-
tients progress rapidly from paroxysmal AF to persistent
AF (on the order of months) whilst other patients do
not progress at all (measured over decades) [6]. Further-
more, patients with a high fibrosis burden can remain
paroxysmal and those with low fibrosis burden can be in
persistent AF [6–9].
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2Thus we have the following recent clinical observations:
(1) AF burden does not inexorably increase and can even
spontaneously decrease therefore not all patients appear
to progress to persistent AF, (2) persistent AF can remit
to paroxysmal AF, (3) the common conception that fibro-
sis correlates with AF progression needs to be reconciled
with the observed variability in AF burden for patients
with similar levels of fibrosis. Individually and collec-
tively these studies challenge the contemporary view of
how AF evolves. Although it has been suggested that
different pathological processes (mitral valve disease, dia-
betes etc.) occurring in different patients may contribute
to variability in AF progression [10], it is fair to say that
there is no understanding of what causes the clinical ob-
servations summarised above.
The clinical patterns of AF are studied in the domain
of populations on long time-scales (months to years),
whereas the microstructure of myocardium is often stud-
ied in wet labs within the domain of cellular electrophysi-
ology on short time-scales (form seconds to hours). These
two vastly different time scales cannot be related exper-
imentally. Similarly, many models of AF are computa-
tionally intensive due to their complexity. As a result
only short time periods (seconds or minutes) have been
investigated. Thus, these models cannot address ques-
tions pertaining to the long time scales of disease progres-
sion. Previous work by Chang et al. [11] has explored
the two time scales by modelling AF as a simple binary
process which flips between normal sinus rhythm (SR)
and arrhythmia at patient specific rates. But, this study
does not address the question of the microscopic origin
of variability in clinical observations.
We use a very simple computational model to link the
two time domains. The model is specifically designed
to address the hypothesis that the stochastic nature of
transversal uncoupling is an important factor in the tem-
poral patterns of AF. We model a patient by simulating
patient specific tissue using a simple stochastic process,
and then assess the resulting temporal AF patterns.
The incidence of AF increases with age and is strongly
associated with the accumulation of fibrosis [5]. In this
letter we propose that the clinically observed diversity in
AF progression can be caused by a single process, the
progressive stochastic accumulation of transversal cellu-
lar uncoupling. Using a simple computer model we show
that different time-courses of AF can occur between pa-
tients despite a similar degree of transversal cellular un-
coupling. Thus the model provides an explanation to
the aforementioned clinical observations, namely that
(1) the time-course of AF progression can vary signifi-
cantly between patients, (2) persistent AF can remit to
paroxysmal AF, and (3) macrostructurally similar my-
ocardium can show very different AF behaviour as a
result of these microstructural differences. In addition
to this, the model identifies specific critical architectural
patterns of uncoupling between myocytes as the primary
cause of AF induction. When access to the microstruc-
ture becomes available in the future this insight has the
potential to result in patient-specific therapy.
We have previously developed a model in which the
activation wavefronts propagate on an anisotropic struc-
ture mimicking the branching network of heart muscle
cells [12] (see supplementary information for a complete
description of the model). The tissue is represented by a
L×L square grid of discrete cells where each cell is always
coupled to its longitudinal neighbors but with probabil-
ity ν to its transversal neighbors. This generates a lattice
with anisotropic coupling, mimicking the uncoupling of
transversal cell-to-cell connectivity through the param-
eter ν. We use the simplest model of cell kinetics to
mimic the action potential so that a cell may be in one
of three states: resting (repolarized), excited (depolar-
izing), or refractory. An excited cell causes neighboring
coupled resting cells to become excited. Thus the wave-
front is a coherent propagation of this excitation through
the simulated tissue.
For each patient the initial conditions are created by
assigning the same number of vertical connections (iden-
tical initial ν) but at different random positions. Next
the accumulation of transversal cellular uncoupling is im-
plemented by reducing ν (e.g., to mimic the progression
of fibrosis or gap junctional uncoupling). To do this, we
run simulations for a period of T = 4.3×107 time steps in
the computer model and vertical connections are removed
at a rate of one connection every nine thousand time
steps. We note that the actual rate at which transver-
sal uncoupling accumulates in humans is unknown and
may differ between patients. Hence, the rates used in
the model are set to be identical between simulated pa-
tients with the aim of capturing the generic phenomenon
of the accumulation of uncoupling over time thought to
occur frequently in humans [6]. We observe the dynam-
ics of activation wavefronts as the transversal uncoupling
accumulates in the tissue. All other model parameters
are set to physiological values as described in [12] (see
supplementary information).
We ran 32 lattice simulations, representing 32 patients,
with the same initial fraction of vertical connections dis-
tributed randomly in each simulated tissue. We start at
ν = 0.25 where all the simulated heart muscle tissue are
in sinus rhythm (SR) but when lowering ν, fibrillation
may emerge. The number of excited cells can be used
to determine when the system is in fibrillation, see Fig.
1 for example and associated electrogram, and hence de-
termine the associated AF burden which we define as the
amount of time in AF divided by the total observed time.
To define paroxysmal and persistent AF in the model we
use a scheme similar to that of Sugihara et al. based on
AF burden. That is, we call periods of AF burden being
1-99% paroxysmal AF and burden of 100% persistent AF.
Permanent AF traditionally refers to the clinical decision
not to treat and thus is not informative of the dynamics
3of AF.
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FIG. 1: Numerical simulation for a 200 by 200 system where
pacemaker cells activate periodically. a, during sinus rhythm
(SR, blue curve) the number of excited cells varies with the
same period as the pacemaker cells. When the number of
excited cells exceeds a threshold (220, see dashed gray line)
it implies that the system is in fibrillation (AF, black curve).
The system is defined to return to SR when the system is
below threshold for more than one normal sinus rhythm beat.
b, a rectangular electrode of size 1mm2 (10 x 10 cells) placed
at the center of the tissue is used to simulate the electrogram.
During fibrillation (black curve) the rate of the electrogram
increases by a factor of 2-5. c, the associated binary signal of
the time series in a into periods of SR (blue filled area) and
AF (black filled area). Over long-time simulations, the AF
burden can be computed from this as the fraction of time in
AF.
Figure 2 shows the time-course of four particular simu-
lated patients. Patient A undergoes what would be con-
sidered the standard progression from paroxysmal AF,
with low AF burden, to persistent AF, with maximal AF
burden. Patient B, however, shows isolated short-lived
episodes of paroxysmal AF with a sudden cross-over to
persistent AF. Hence, Patient B lacks a gradual progres-
sion from paroxysmal AF to persistent AF. Patient C also
had a few isolated episodes of paroxysmal AF before en-
tering a much more disordered relapsing-remitting phase
between paroxysmal and persistent AF with different AF
burdens compared to Patient B. Patient D underwent a
sudden transition from sinus rhythm to persistent AF,
but has phases of sinus rhythm interrupting persistent
AF during the time-course of the disease.
These four “patients” are archetypes of the time-course
of AF that we observe in our simulations. In addition
to the variability in the progression to persistent AF we
note that the onset of AF occurs at significantly different
amounts of uncoupling, that is, fractions of vertical con-
nections. These findings are consistent with the clinical
observations that macroscopically similar myocardium
can show large variability in AF burden [3, 6].
Furthermore, we observe that AF activity tends to
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FIG. 2: AF burden varies with time, calculated from the
time in AF in a sliding window of 5× 106 time steps for four
different“patients”. Each simulation begins with an initial
fraction of vertical connections of ν = 0.25 and is depleted to
ν = 0.13 mimicking progression of stochastic uncoupling over
a simulated time period of 4.3× 107 time steps. a, “Patient”
A develops paroxysmal AF for ν . 0.188 which eventually
develops into persistent AF at ν . 0.138. b, “Patient” B
develops short lived episodes of AF for 0.206 . ν . 0.238
and a sudden transitions into persistent AF ν ≈ 0.206. This
relapses into paroxysmal AF three times before remitting back
into persistent AF at ν ≈ 0.166. c, “Patient” C shows a
phase of relapsing-remitting paroxysmal to persistent AF for
a considerable period of time until AF becomes persistent at
ν ≈ 0.159. d, “Patient” D shows isolated short lived episodes
of AF and a sudden transition into persistent AF ν ≈ 0.164.
Remission back into sinus rhythm occurs twice (ν ≈ 0.156
and ν ≈ 0.145) before AF becomes persistent. The vertical
dashed lines are values of fractions of vertical connections at
which simulations are re-run without progressive uncoupling,
that is, with a fixed fraction of vertical connections (see Fig.
3).
change suddenly. That is, the frequency and duration of
AF episodes change rapidly rather than gradually with
progressive uncoupling (see Fig. 3). This is consistent
with the clinical observation that macrostructurally sim-
ilar myocardium (e.g., quantified by the global average
fibrosis burden) show very different AF characteristics
[6]. The frequency and duration of AF events are differ-
ent in each simulated patients. However, in addition to
clinical studies we can identify the microscopic origins of
the observed behaviour.
The differences in the behaviour of these simulations
are explained to a large degree by the number of localised
critical regions with specific architectural patterns of cou-
pling observed in the simulated tissues. In the model we
detect these critical regions by detecting complete loops
of wavefront activation, that is, micro-re-entrant circuits.
However, these critical patterns of uncoupling might also
be determined structurally as these local patches of tis-
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FIG. 3: Seven snapshots at ν = 0.220, 0.206, 0.178, 0.172,
0.160, 0.156 and 0.131 of variability in event duration (ex-
pressed as a fraction of the simulation time 1.2 × 107 time
steps), number of AF events and AF burden for repeated
simulations as a function of fraction of vertical connections.
We re-run the simulations shown in Fig. 2 for 1.2× 107 time
steps starting from particular values of the fraction vertical
connections (see vertical dashed lines in Fig. 2) in which at
least one of the four simulations displayed non sinus rhythm
behavior. Note that we see variability both within a “patient”
as the time-course of AF progresses as well as between “pa-
tients”. These three observables of event duration, number
of AF events and AF burden are seen to vary significantly
between real patients as well [3].
sue have connections and dysfunctional cells arranged
in a configuration which allows the formation of pinned
micro-re-entrant circuits [12]. These regions are charac-
terised by large contiguous regions of uncoupled cell akin
to the obstructive fibrosis found to promote AF in goats
[13]. We observe that the first occurrence of AF coincide
with the (chance) emergence of the first critical struc-
ture at ν = 0.188, 0.238, 0.228 and 0.177 for Patient A,
B, C and D, respectively, see Fig. 4. Furthermore, the
number of these critical regions vary between “patients”
despite having the same fraction of vertical connections
(macroscopic measure). It is the variation in the number
of these critical regions that causes the variability in the
observed AF behaviour shown in Figures 2 and 3, see Fig.
4 e (see also full set of 32 “patients” in supplementary
materials).
The progression of AF and its variability is poorly un-
derstood. Fibrosis, among other factors, is known to be
important. However, the reason why so much heterogene-
ity in AF behaviour occurs in patients with similar fibro-
sis burden is not known. In addition to this, insights from
studies in cardiac tissue slices (short time-scales) have yet
to be reconciled with the clinical patterns of AF develop-
ment (long time scales). We bridge this gap using compu-
tational modelling and identify how structural character-
istics of myocardium and uncoupling alone can give rise
to patient variability. We note that the variability in the
simulated patients is strictly due to specific architectural
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FIG. 4: a-d, Accumulation of initiating critical regions (black
curve) versus the fraction of vertical connections for “pa-
tients” A-D. The onset of AF in each “patient” coincide with
the first appearance of a critical region. As uncoupling pro-
gresses (the fraction of vertical connections is reduced), the
number of initiating critical regions increases. e, The average
AF burden for each “patient” as a function of the number of
critical regions. The differences in the accumulation of criti-
cal regions between “patients” better predicts the variability
in the AF behavior observed.
patterns of vertical uncoupling between cells. Fibrosis
is one mechanism of cellular uncoupling. An additional
mechanism of uncoupling is gap junctional remodelling,
whereby the passive high resistance pathways between
cells are redistributed to enhance anisotropic conduction
and may result in the failure of action potential prop-
agation [14–16]. Indeed, gap junctional remodelling is
known to be arrhythmogenic.
We show that a simple model of heart muscle tissue
can display the clinically observed variability in AF pro-
gression. This variability originates from the chance oc-
5currence of critical regions characterised by poor vertical
connectivity. The model reproduces clinical observations:
variability in AF episode onset time, frequency, duration
and progression (Fig. 3) along with (1) significant vari-
ability in the time-course of AF progression between pa-
tients (2) persistent AF remitting to paroxysmal AF and
(3) macrostructurally similar myocardium can show very
different AF behaviour (Figs. 2 and 4) Thus we show that
a single pathological mechanism, namely uncoupling, can
result in patterns of AF observed clinically. Specific ar-
chitectural patterns of uncoupling rather than the global
uncoupling (e.g., total fibrosis burden) were observed to
drive AF. Thus, our work suggests that the tissue mi-
crostructure is essential in determining the time-course
of AF in a given patient. This is a first step in relat-
ing structural features of myocardium, greatly studied in
a basic science context, to patterns of AF in patients,
studied in a clinical context. When experimental access
to in vivo tissue microstructure becomes available in the
future insight from this work might potentially lead to
patient-specific therapy.
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